» Articles » PMID: 35608733

First Baseline Data of the Klinefelter ItaliaN Group (KING) Cohort: Clinical Features of Adult with Klinefelter Syndrome in Italy

Abstract

Background: Klinefelter syndrome (KS) is frustratingly under-diagnosed. KS have a broad spectrum of clinical features, making it difficult to identify.  OBJECTIVE: We describe KS clinical presentation in a large Italian cohort.

Design: This is the first observational cohort study within a national network, the Klinefelter ItaliaN Group (KING). Primary outcomes were to describe the basic clinical features and the actual phenotype of KS in Italy. Secondary outcomes were to determine age at diagnosis and geographical distribution.

Methods: We performed a basic phenotyping and evaluation of the hormonal values of 609 adult KS patients.

Results: Mean age at diagnosis was 37.4 ± 13.4 years. The overall mean testicular size was 3 ml, and 2.5 ml in both testes in untreated KS group. BMI was 26.6 ± 5.8 kg/m, and 25.5% of KS had metabolic syndrome (MetS). LH and FSH were increased, and mean total testosterone were 350 ± 9.1 ng/dl. A descriptive analysis showed that 329 KS patients were evaluated in Northern Italy, 76 in Central and 204 in Southern Italy. Analysis of variance demonstrated significant statistical differences (p < 0001) between the age at diagnosis of the three geographical groups. Compared with the expected number among male patients matched for age in Italy, only 16% of KS patients received a diagnosis.

Conclusions: These data are the results of the only national database available that collects the clinical and hormonal data of the KS patients, currently referred at the KING centers. In Italy the typical KS patient is overweight, with small testes, and elevated LH and FSH. Only 25.5% of them are diagnosed with MetS. Early detection and timely treatment are mandatory.

Citing Articles

The correlation between clinical features and ultrastructure of testis of non-mosaic Klinefelter's syndrome patients with hypogonadism and androgen deficiency: A case report.

Zhang B, Li F, Huang C, Xu L, Cao Z, Kang Y Heliyon. 2023; 9(9):e19940.

PMID: 37809695 PMC: 10559353. DOI: 10.1016/j.heliyon.2023.e19940.


Reproductive hormones, bone mineral content, body composition, and testosterone therapy in boys and adolescents with Klinefelter syndrome.

Lopez Krabbe H, Petersen J, Asserhoj L, Holm Johannsen T, Christiansen P, Jensen R Endocr Connect. 2023; 12(7).

PMID: 37010084 PMC: 10305500. DOI: 10.1530/EC-23-0031.

References
1.
Berglund A, Viuff M, Skakkebaek A, Chang S, Stochholm K, Gravholt C . Changes in the cohort composition of turner syndrome and severe non-diagnosis of Klinefelter, 47,XXX and 47,XYY syndrome: a nationwide cohort study. Orphanet J Rare Dis. 2019; 14(1):16. PMC: 6332849. DOI: 10.1186/s13023-018-0976-2. View

2.
Salzano A, DAssante R, Heaney L, Monaco F, Rengo G, Valente P . Klinefelter syndrome, insulin resistance, metabolic syndrome, and diabetes: review of literature and clinical perspectives. Endocrine. 2018; 61(2):194-203. DOI: 10.1007/s12020-018-1584-6. View

3.
Bojesen A, Juul S, Birkebaek N, Gravholt C . Morbidity in Klinefelter syndrome: a Danish register study based on hospital discharge diagnoses. J Clin Endocrinol Metab. 2006; 91(4):1254-60. DOI: 10.1210/jc.2005-0697. View

4.
Samuelson G . Dietary habits and nutritional status in adolescents over Europe. An overview of current studies in the Nordic countries. Eur J Clin Nutr. 2000; 54 Suppl 1:S21-8. DOI: 10.1038/sj.ejcn.1600980. View

5.
Gies I, Unuane D, Velkeniers B, De Schepper J . Management of Klinefelter syndrome during transition. Eur J Endocrinol. 2014; 171(2):R67-77. DOI: 10.1530/EJE-14-0213. View